SENP1 and cardiovascular disorder: In the previous studies, we showed GA can inhibit SENP1 and can be explored as a drug for cancer treatment (Taghvaei et al., 2021b) and Bethanidine with SENP1 inhibition can be a suitable candidate against cardiovascular diseases (Taghvaei et al., 2021a).